Noventra Pharma | Tirzepatide 60mg (Research) | Compound Peptide Pen
Advanced Dual GIP/GLP-1 Receptor Research Compound
Noventra Pharma Tirzepatide 60mg is an investigational peptide research compound studied for its dual receptor activity across GIP and GLP-1 pathways, widely referenced in laboratory research exploring metabolic regulation, insulin signalling, and energy homeostasis mechanisms.
Tirzepatide is commonly investigated in scientific models focused on glucose metabolism, appetite regulation pathways, and multi-receptor endocrine signalling within controlled experimental environments.
Developed as a 60mg compound peptide pen, this formulation is designed for laboratory preparation and controlled research applications where dual incretin receptor activity and metabolic pathway analysis are of scientific interest.
Noventra Pharma Tirzepatide 60mg Compound Peptide Pen
• Dual GIP/GLP-1 receptor research compound studied in metabolic signalling models
• Investigated in insulin response and glucose regulation research
• Of interest in appetite control and energy balance pathway studies
• Explored in multi-receptor endocrine signalling research environments
• 60mg pen format designed for laboratory preparation use
• High-purity investigational formulation from Noventra Pharma
• Manufactured for stability, consistency, and research reliability
• Strictly intended for laboratory research use only
⚖️ DISCLAIMER
This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPHRA) for human or animal use.
This product is supplied strictly for laboratory research purposes only and is not intended for human consumption.
Products sold on this website are not intended to diagnose, treat, cure, or prevent any disease.
